Assuta Medical Center, Tel Aviv, Israel.
Department of General Surgery, Holy Family Hospital, Nazareth, Israel.
World J Surg. 2024 Jun;48(6):1458-1466. doi: 10.1002/wjs.12182. Epub 2024 Apr 9.
The extremely obese patient deserves special consideration: significant comorbidities, technical difficulties, and increased postoperative morbidity and mortality are all expected in this patient population. The study compared early postoperative complications (≤30-day) following one-anastomosis gastric bypass (OAGB) morbidity in patients with morbid obesity class IV obesity, body mass index (BMI) ≥50-59.9 kg/m, and class V obesity, BMI ≥60 patients.
We retrospectively reviewed perioperative OAGB outcomes in three BMI groups. Operative time, length of stay (LOS), and overall early postoperative complication rates were studied. Patient-reported complications were ranked by Clavien-Dindo Classification (CDC).
Between January 2017-December 2021, consecutive patients with obesity class III (n = 2950), IV (n = 256), and V (n = 23) underwent OAGB. BMI groups were comparable in sex, age, and associated comorbidities. Mean operative time was significantly longer in the higher BMI groups: class III (66.5 ± 25.6 min), IV (70.5 ± 28.7 min), and V (80.0 ± 34.7 min), respectively (p = 0.018); no difference in LOS. In respective BMI classes, ≤30-day complication rates were 3.2%, 3.5%, and 4.3% (p = 0.926). The respective number of patients with CDC grades of one to two were 45 (1.5%), 6 (2.3%), and 1 (4.3%), p = 0.500; and in grade ≥3a, 25 (0.8%), 1 (0.4%), 0 (0.0%), p = 0.669. There was 0.06% mortality (n = 2 in 3229), both in BMI class III.
OAGB is a safe BS procedure in patients with class III, IV, and V obesity in the perioperative term with comparable ≤30-day morbidity in the three BMI groups.
极度肥胖的患者需要特别关注:在这类患者群体中,预计会出现显著的合并症、技术困难以及更高的术后发病率和死亡率。本研究比较了病态肥胖 IV 级肥胖(BMI≥50-59.9kg/m²)和 V 级肥胖(BMI≥60)患者接受单吻合口胃旁路术(OAGB)后 30 天内(早期)的术后并发症。
我们回顾性分析了三组 BMI 患者的 OAGB 围手术期结果。研究了手术时间、住院时间(LOS)和总体早期术后并发症发生率。患者报告的并发症按 Clavien-Dindo 分类(CDC)进行分级。
2017 年 1 月至 2021 年 12 月,连续接受 OAGB 治疗的肥胖 III 级(n=2950)、IV 级(n=256)和 V 级(n=23)患者。BMI 组在性别、年龄和并存合并症方面无差异。较高 BMI 组的手术时间明显更长:III 级(66.5±25.6 分钟)、IV 级(70.5±28.7 分钟)和 V 级(80.0±34.7 分钟)(p=0.018);LOS 无差异。在各自的 BMI 级别中,30 天内并发症发生率分别为 3.2%、3.5%和 4.3%(p=0.926)。相应的 CDC 1-2 级患者人数分别为 45 例(1.5%)、6 例(2.3%)和 1 例(4.3%),p=0.500;3a 级及以上的分别为 25 例(0.8%)、1 例(0.4%)和 0 例(0.0%),p=0.669。3229 例患者中有 0.06%的死亡率(n=2),均发生在 BMI 级 III 组。
在围手术期,OAGB 是一种安全的 BS 手术,适用于 III、IV 和 V 级肥胖患者,三组 BMI 的 30 天内发病率相似。